MMWClass II
System, Test, Tumor Marker, Monitoring, Bladder
21 CFR 866.6010 / Immunology
MMW is the FDA product code for System, Test, Tumor Marker, Monitoring, Bladder, a class II device type, regulated under 21 CFR 866.6010. As of , FDA records hold 9 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- MMW
- Device name
- System, Test, Tumor Marker, Monitoring, Bladder
- Regulation
- 21 CFR 866.6010
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 9
- Ingested recalls
- 1
Clearances, product code MMW
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1997 | 2 |
| 1998 | 2 |
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 1 |
| 2023 | 1 |
Applicants with the most clearances
Product code MMW| Applicant | Clearances |
|---|---|
| Bard Diagnostic Sciences,Inc. | 3 |
| Vysis | 3 |
| Matritech, Inc. | 1 |
| Nucleix Ltd. | 1 |
| Perimmune, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
